Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | ACE | P12821 | 3/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | APAF1 | O14727 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | MPO | P05164 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.63 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.62 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.62 |
| ▸ | ITGAL | P20701 | 3/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20816097 | 1.00 | ALOX15 (0.67) | ALOX15ACESMN1; SMN2KDM4EMAPT | |
| SCHEMBL18830959 | 1.00 | ALOX15 (0.67) | ALOX15ACESMN1; SMN2KDM4EMAPT | |
| SCHEMBL29429239 | 1.00 | ALOX15 (0.67) | ALOX15ACESMN1; SMN2KDM4EMAPT | |
| SCHEMBL30782236 | 0.88 | ALOX15 (0.70) | ALOX15ACESMN1; SMN2KDM4EMAPT | |
| SCHEMBL19090900 | 0.87 | ECE1 (0.61) | ALOX15ACESMN1; SMN2KDM4EMAPT | |
| SCHEMBL170878 | 0.87 | KDM4E (0.69) | ALOX15ACESMN1; SMN2KDM4EMAPT | |
| SCHEMBL2167226 | 0.87 | ALOX15 (0.68) | ALOX15ACESMN1; SMN2KDM4EMAPT | |
| SCHEMBL170877 | 0.87 | KDM4E (0.69) | ALOX15ACESMN1; SMN2KDM4EMAPT | |
| SCHEMBL1755294 | 0.87 | ALOX15 (0.68) | ALOX15ACESMN1; SMN2KDM4EMAPT | |
| SCHEMBL15226899 | 0.86 | ALOX15 (0.64) | ALOX15ACESMN1; SMN2KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12587105-B2 | Power converter | MITSUBISHI ELECTRIC CORPORATION (JP) | 2026-03-24 | — | — | US | disclosed |
| US-20250260328-A1 | POWER CONVERSION DEVICE | MITSUBISHI ELECTRIC CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| US-12319946-B2 | Methods for producing modified bacteria for production of nitroaromatics | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2025-06-03 | — | — | US | disclosed |
| CN-115894574-B | Polysubstituted ferrocene-Cu+Chiral material, preparation method and application thereof in electrochemical chiral recognition | 常州大学 | 2025-04-11 | — | — | CN | disclosed |
| US-20250042961-A1 | P53 PEPTIDOMIMETIC MACROCYCLES | AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH (SG) | 2025-02-06 | — | — | US | disclosed |
| US-20240417764-A1 | METHODS FOR THE PRODUCTION OF TRYPTOPHANS, TRYPTAMINES, INTERMEDIATES, SIDE PRODUCTS AND DERIVATIVES | MIAMI UNIVERSITY | 2024-12-19 | — | — | US | disclosed |
| US-20240413759-A1 | POWER CONVERTER | MITSUBISHI ELECTRIC CORPORATION (JP) | 2024-12-12 | — | — | US | disclosed |
| EP-4426676-A2 | METHODS FOR THE PRODUCTION OF TRYPTOPHANS, TRYPTAMINES, INTERMEDIATES, SIDE PRODUCTS AND DERIVATIVES | MIAMI UNIVERSITY (US) | 2024-09-11 | — | — | EP | disclosed |
| US-20240229090-A1 | MODIFIED BACTERIA FOR PRODUCTION OF NITROAROMATICS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240159741-A1 | NEW TREATMENT AND PREVENTION BASED ON NEW METHOD FOR CONTROLLING CELLULAR IMMUNITY | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2024-05-16 | — | — | US | disclosed |
| WO-2023209821-A1 | POWER CONVERSION DEVICE | 三菱電機株式会社 | 2023-11-02 | — | — | WO | disclosed |
| WO-2023084598-A1 | POWER CONVERSION DEVICE | 三菱電機株式会社 | 2023-05-19 | — | — | WO | disclosed |
| WO-2023081837-A2 | METHODS FOR THE PRODUCTION OF TRYPTOPHANS, TRYPTAMINES, INTERMEDIATES, SIDE PRODUCTS AND DERIVATIVES | MIAMI UNIVERSITY (US) | 2023-05-11 | — | — | WO | disclosed |
| US-20220401545-A1 | NOVEL TREATMENT AND PREVENTION OF DISEASE BASED ON IMMUNOLOGICAL MEMORY | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2022-12-22 | — | — | US | disclosed |
| EP-4096786-A1 | GENE THERAPY FOR NEURODEGENERATIVE DISORDERS USING POLYNUCLEOTIDE SILENCING AND REPLACEMENT | Paros Bio, Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| WO-2022176920-A1 | NEW TREATMENT AND PREVENTION BASED ON NEW METHOD FOR CONTROLLING CELLULAR IMMUNITY | ゼリア新薬工業株式会社 | 2022-08-25 | — | — | WO | disclosed |
| EP-4014988-A1 | NOVEL TREATMENT AND PREVENTION OF DISEASE BASED ON IMMUNOLOGICAL MEMORY | National Institutes of Biomedical Innovation, Health and Nutrition (JP) | 2022-06-22 | — | — | EP | disclosed |
| CN-114641309-A | Novel immune memory-based disease treatment and prevention | 国立研究开发法人医药基盤·健康·荣养研究所 | 2022-06-17 | — | — | CN | disclosed |
| WO-2022123653-A1 | ELECTRIC POWER CONVERSION UNIT AND ELECTRIC POWER CONVERSION DEVICE | 三菱電機株式会社 | 2022-06-16 | — | — | WO | disclosed |
| CN-114047238-A | L-His-ZIF-8 chiral material, preparation method and application | 常州大学 | 2022-02-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12587105-B2 | Power converter | PDHB, DUOX2, PDHA1 | ALOX15 4307/4885ACE 2330/4885SMN1; SMN2 1314/4885 |
| US-20250042961-A1 | P53 PEPTIDOMIMETIC MACROCYCLES | TP53, MDM2, MDM4 | ALOX15 2855/4885ACE 2541/4885SMN1; SMN2 4356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.